FEATURED:

Lawmakers press FDA for action on addictive painkillers

Lawmakers asked the FDA for a specific timeline on how quickly hydrocodone medications could be taken from a Schedule III drug to a Schedule II, which would make them harder to get. 

“The American people have waited too long for action from this agency,” the lawmakers wrote in a letter to the FDA. “Your own experts agreed it is time we take the necessary steps to address this deadly epidemic.”

ADVERTISEMENT
Reps. Vern Buchanan (R-Fla.) and Edward MarkeyEdward (Ed) John MarkeySenate receives official net neutrality notice from FCC EPA chief braces for grilling from Senate Dems Trump’s former chemical safety nominee leaving EPA MORE (D-Mass.) signed the letter, along with Sens. Joe ManchinJoseph (Joe) ManchinMcConnell: 'Whoever gets to 60 wins' on immigration Manchin: Senators should sign pledge not to campaign against each other  GOP senators turning Trump immigration framework into legislation MORE (D-W.Va.), Mark KirkMark Steven KirkHigh stakes as Trump heads to Hill Five things to watch for at Trump-Senate GOP meeting Giffords, Scalise highlight party differences on guns MORE (R-Ill.), John RockefellerJohn (Jay) Davison RockefellerOvernight Tech: Trump nominates Dem to FCC | Facebook pulls suspected baseball gunman's pages | Uber board member resigns after sexist comment Trump nominates former FCC Dem for another term Obama to preserve torture report in presidential papers MORE (D-W.Va.), Charles SchumerCharles (Chuck) Ellis SchumerGOP lawmaker: Dems not standing for Trump is 'un-American' Trump called for unity — he didn’t even last a week Overnight Defense: GOP plays hardball by attaching defense funding to CR | US reportedly drawing down in Iraq | Russia, US meet arms treaty deadline | Why the military wants 6B from Congress MORE (D-N.Y.) and Kirsten GillibrandKirsten Elizabeth GillibrandBritish health secretary fires back at Trump over universal health care claims Trump on Dems’ ‘universal' health-care push: ‘No thanks’ Gillibrand calls for DOJ to investigate US Olympic Committee over abuse scandal MORE (D-N.Y.).

The lawmakers noted that the number of chronic abusers of hydrocodone in the U.S. has increased to more than 24 million since 1999, when Congress originally asked the agencies to work on the issue. 

“It has been 14 years since the initial petition requesting that the FDA and [the Drug Enforcement Agency] evaluate the proper scheduling of hydrocodone combination drugs. In those 14 years, there has been a staggering number of hydrocodone related deaths and a drastic increase in non-medical users of these products,” lawmakers wrote.

Moving hydrocodone combination drugs from a Schedule III to a Schedule II classification would make a doctor’s written prescription mandatory to obtain the medications, among other restrictions.  

Lawmakers said 139 million prescriptions of hydrocodone-based painkillers have been sold since 2010, making them the top-selling controlled substance in America.

The FDA announced it would move to address the availability of the drugs last month, following a 19-10 vote by an advisory panel that agreed new restrictions are needed.